Patient Webinar: Immunotherapy in Cancer – How It Works and Why Challenges Remain

Patient Webinar: Immunotherapy in Cancer – How It Works and Why Challenges Remain

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

We invite cancer patients, relatives, and caregivers to join our patient webinar, where we will explain the basics of immunotherapy, discuss current challenges, and highlight how patient involvement is essential to improving future treatments.

🗓 When: Thursday, 23 April 2026
🕓 Time: 4:00 PM

The 1-hour webinar will consist of three topics (10-15 minutes each), followed by a question-and-answer slot.

Agenda

  • The Immune SystemUzma Hassan
    (CRCL – The Lyon Immunotherapy for Cancer Laboratory (LICL), France)
  • Immunotherapy: Treatments and Cancer TypesGianmarco Contino
    (University of Birmingham, United Kingdom)
  • Immuno-models, COST Action, future activities & the role of patients
    Eva Martínez Balibrea
    (Chair of the COST Action; Catalan Institute of Oncology, Spain)
    &
    Leticia Oliveira-Ferrer
    (Vice-Chair of the COST Action; University Medical Center Hamburg-Eppendorf, Germany)

🎤 Moderator:
Silke Vogel (Patient Advocate)

🌍 Who we are

We are IMMUNO-model, a European research consortium working under the umbrella of a COST Action. Our objective is to contribute to the development of more effective and less toxic immunotherapies by advancing preclinical immuno-models that better reflect patient reality.

Our Patient Engagement Task Force aims to bring these concepts to as many patients as possible. Interaction with patients is essential to help us shape relevant research questions, refine our models, and guide future research topics.

Teams link: 11th IMMUNO-model webinar: Patient Webinar: Immunotherapy in Cancer – How It Works and Why Challenges Remain | Partecipazione alla riunione | Microsoft Teams

Registration form link: https://forms.gle/W8J9rHn6QqTKccHz6

Latest Updates

STSM: Short Term Scientific Mission Visit to a host organization located in a different country than the country of affiliation by a researcher or innovator for specific work to be...
Patients’ Webinar: Immunotherapy in Cancer – How It Works and Why Challenges Remain April 23rd, at 4 pm CETLive on TEAMs platform Speakers Dr. Uzma Hassan, CRCL – The Lyon...
The @immunomodel COST Action workshop MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY, organized by @MarValesLab CNB-CSIC, brought together leading international experts...
IMMUNO-model released Annual report for Grant Period 3, in which activities and achievements of IMMUNO-model are summarized
We’re excited to share the latest addition to the IMMUNOmodel Knowledge Hub:👉 “Invasion/Chemotaxis-on-chip” by Devrim Pesen Okvur🔗 https://osf.io/yws9r/files/7sqye  This step-by-step protocol details how to study cell invasion and chemotaxis in 3D...
Date and place: 20-22 May 2026, National Institute of Biology, Ljubljana, Slovenia We are delighted to announce the Final IMMUNO-model Annual Conference – Building Bridges in Cancer Immunotherapy Modelling, where...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter